|
1
|
Gao J, Wang Z, Liu H, Wang L and Huang G:
Liposome encapsulated of temozolomide for the treatment of glioma
tumor: Preparation, characterization and evaluation. Drug Discov
Ther. 9:205–212. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kawaji H, Tokuyama T, Yamasaki T, Amano S,
Sakai N and Namba H: Interferon-β and temozolomide combination
therapy for temozolomide monotherapy-refractory malignant gliomas.
Mol Clin Oncol. 3:909–913. 2015.PubMed/NCBI
|
|
3
|
Yu Z, Xie G, Zhou G, Cheng Y, Zhang G, Yao
G, Chen Y, Li Y and Zhao G: NVP-BEZ235, a novel dual PI3K-mTOR
inhibitor displays anti-glioma activity and reduces chemoresistance
to temozolomide in human glioma cells. Cancer Lett. 367:58–68.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang X, Jia L, Jin X, Liu Q, Cao W, Gao X,
Yang M and Sun B: NF-κB inhibitor reverses temozolomide resistance
in human glioma TR/U251 cells. Oncol Lett. 9:2586–2590.
2015.PubMed/NCBI
|
|
5
|
Tian T, Li A, Lu H, Luo R, Zhang M and Li
Z: TAZ promotes temozolomide resistance by upregulating MCL-1 in
human glioma cells. Biochem Biophys Res Commun. 463:638–643. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhou Q: BMS-536924, an ATP-competitive
IGF-1R/IR inhibitor, decreases viability and migration of
temozolomide-resistant glioma cells in vitro and suppresses tumor
growth in vivo. Onco Targets Ther. 8:689–697. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Huang Q, Lu G, Shen HM, Chung MC and Ong
CN: Anti-cancer properties of anthraquinones from rhubarb. Med Res
Rev. 27:609–630. 2007. View Article : Google Scholar
|
|
8
|
Tamura T, Yokoyama T and Ohmori K: Effects
of diacerein on indomethacin-induced gastric ulceration.
Pharmacology. 63:228–233. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhong XF, Huang GD, Luo T, Deng ZY and Hu
JN: Protective effect of rhein against oxidative stress-related
endothelial cell injury. Mol Med Rep. 5:1261–1266. 2012.PubMed/NCBI
|
|
10
|
Zhao YL, Zhou GD, Yang HB, Wang JB, Shan
LM, Li RS and Xiao XH: Rhein protects against acetaminophen-induced
hepatic and renal toxicity. Food Chem Toxicol. 49:1705–1710. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hu G, Liu J, Zhen YZ, Wei J, Qiao Y, Lin
YJ and Tu P: Rhein inhibits the expression of vascular cell
adhesion molecule 1 in human umbilical vein endothelial cells with
or without lipopolysaccharide stimulation. Am J Chin Med.
41:473–485. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cong XD, Ding MJ, Dai DZ, Wu Y, Zhang Y
and Dai Y: ER stress, p66shc, and p-Akt/Akt mediate
adjuvant-induced inflammation, which is blunted by argirein, a
supermolecule and rhein in rats. Inflammation. 35:1031–1040. 2012.
View Article : Google Scholar
|
|
13
|
Barnard DL, Huffman JH, Morris JL, Wood
SG, Hughes BG and Sidwell RW: Evaluation of the antiviral activity
of anthraquinones, anthrones and anthraquinone derivatives against
human cytomegalovirus. Antiviral Res. 17:63–77. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cyong J, Matsumoto T, Arakawa K, Kiyohara
H, Yamada H and Otsuka Y: Anti-bacteroides fragilis substance from
rhubarb. J Ethnopharmacol. 19:279–283. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Agarwal SK, Singh SS, Verma S and Kumar S:
Antifungal activity of anthraquinone derivatives from Rheum emodi.
J Ethnopharmacol. 72:43–46. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Singh B, Nadkarni JR, Vishwakarma RA,
Bharate SB, Nivsarkar M and Anandjiwala S: The hydroalcoholic
extract of Cassia alata (Linn.) leaves and its major compound rhein
exhibits antiallergic activity via mast cell stabilization and
lipoxygenase inhibition. J Ethnopharmacol. 141:469–473. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lin ML, Chung JG, Lu YC, Yang CY and Chen
SS: Rhein inhibits invasion and migration of human nasopharyngeal
carcinoma cells in vitro by down-regulation of matrix
metalloproteinases-9 and vascular endothelial growth factor. Oral
Oncol. 45:531–537. 2009. View Article : Google Scholar
|
|
18
|
Fernand VE, Losso JN, Truax RE, Villar EE,
Bwambok DK, Fakayode SO, Lowry M and Warner IM: Rhein inhibits
angio-genesis and the viability of hormone-dependent and
-independent cancer cells under normoxic or hypoxic conditions in
vitro. Chem Biol Interact. 192:220–232. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen YY, Chiang SY, Lin JG, Ma YS, Liao
CL, Weng SW, Lai TY and Chung JG: Emodin, aloe-emodin and rhein
inhibit migration and invasion in human tongue cancer SCC-4 cells
through the inhibition of gene expression of matrix
metalloproteinase-9. Int J Oncol. 36:1113–1120. 2010.PubMed/NCBI
|
|
20
|
Shi P, Huang Z and Chen G: Rhein induces
apoptosis and cell cycle arrest in human hepatocellular carcinoma
BEL-7402 cells. Am J Chin Med. 36:805–813. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hsia TC, Yang JS, Chen GW, Chiu TH, Lu HF,
Yang MD, Yu FS, Liu KC, Lai KC, Lin CC, et al: The roles of
endoplasmic reticulum stress and Ca2+ on rhein-induced
apoptosis in A-549 human lung cancer cells. Anticancer Res.
29:309–318. 2009.PubMed/NCBI
|
|
22
|
Tsang SW and Bian ZX: Anti-fibrotic and
anti-tumorigenic effects of rhein, a natural anthraquinone
derivative, in mammalian stellate and carcinoma cells. Phytother
Res. 29:407–414. 2015. View
Article : Google Scholar
|
|
23
|
Huang HJ, Lin CC, Chou HC, Chen YW, Lin
ST, Lin YC, Lin DY, Lyu KW and Chan HL: Proteomic analysis of
rhein-induced cyt: ER stress mediates cell death in breast cancer
cells. Mol Biosyst. 10:3086–3100. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Du Q, Bian XL, Xu XL, Zhu B, Yu B and Zhai
Q: Role of mitochondrial permeability transition in human
hepatocellular carcinoma Hep-G2 cell death induced by rhein.
Fitoterapia. 91:68–73. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lin YJ and Zhen YS: Rhein lysinate
suppresses the growth of breast cancer cells and potentiates the
inhibitory effect of Taxol in athymic mice. Anticancer Drugs.
20:65–72. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lin YJ, Zhen YZ, Shang BY and Zhen YS:
Rhein lysinate suppresses the growth of tumor cells and increases
the anti-tumor activity of Taxol in mice. Am J Chin Med.
37:923–931. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhen YZ, Lin YJ, Gao JL, Zhao YF and Xu
AJ: Rhein lysinate inhibits cell growth by modulating various
mitogen-activated protein kinases in cervical cancer cells. Oncol
Lett. 2:129–133. 2011.PubMed/NCBI
|
|
28
|
Lin YJ, Zhen YZ, Zhao YF, Wei J and Hu G:
Rhein lysinate induced S-phase arrest and increased the anti-tumor
activity of 5-FU in HeLa cells. Am J Chin Med. 39:817–825. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhen YZ, Hu G, Zhao YF, Yan F, Li R, Gao
JL and Lin YJ: Synergy of Taxol and rhein lysinate associated with
the down-regulation of ERK activation in lung carcinoma cells.
Oncol Lett. 6:525–528. 2013.PubMed/NCBI
|
|
30
|
Reardon DA, Galanis E, DeGroot JF,
Cloughesy TF, Wefel JS, Lamborn KR, Lassman AB, Gilbert MR, Sampson
JH, Wick W, et al: Clinical trial end points for high-grade glioma:
The evolving landscape. Neuro-oncol. 13:353–361. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chastagner P, Sudour H, Mriouah J,
Barberi-Heyob M, Bernier-Chastagner V and Pinel S: Preclinical
studies of pegylated- and non-pegylated liposomal forms of
doxorubicin as radiosensitizer on orthotopic high-grade glioma
xenografts. Pharm Res. 32:158–166. 2015. View Article : Google Scholar
|
|
32
|
Li XQ, Ouyang ZG, Zhang SH, Liu H, Shang
Y, Li Y and Zhen YS: Synergistic inhibition of angiogenesis and
glioma cell-induced angiogenesis by the combination of temozolomide
and enediyne antibiotic lidamycin. Cancer Biol Ther. 15:398–408.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang L and Zhao D: Liposomal
encapsulation enhances in vivo near infrared imaging of exposed
phosphatidylserine in a mouse glioma model. Molecules.
18:14613–14628. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Polunas M, Halladay A, Tjalkens RB,
Philbert MA, Lowndes H and Reuhl K: Role of oxidative stress and
the mitochondrial permeability transition in methylmercury
cytotoxicity. Neurotoxicology. 32:526–534. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li JP: Resveratrol caused apoptosis in
QGY-7701 cells. Eur Rev Med Pharmacol Sci. 19:3303–3308.
2015.PubMed/NCBI
|
|
36
|
Ma YX, Guo Z and Sun T: CGRP inhibits
norepinephrine induced apoptosis with restoration of Bcl-2/Bax in
cultured cardiomyocytes of rat. Neurosci Lett. 549:130–134. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zeng C, Ke Z, Song Y, Yao Y, Hu X, Zhang
M, Li H and Yin J: Annexin A3 is associated with a poor prognosis
in breast cancer and participates in the modulation of apoptosis in
vitro by affecting the Bcl-2/Bax balance. Exp Mol Pathol. 95:23–31.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Reed JC, Miyashita T, Takayama S, Wang HG,
Sato T, Krajewski S, Aimé-Sempé C, Bodrug S, Kitada S and Hanada M:
BCL-2 family proteins: Regulators of cell death involved in the
pathogenesis of cancer and resistance to therapy. J Cell Biochem.
60:23–32. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Labi V, Woess C, Tuzlak S, Erlacher M,
Bouillet P, Strasser A, Tzankov A and Villunger A: Deregulated cell
death and lymphocyte homeostasis cause premature lethality in mice
lacking the BH3-only proteins Bim and Bmf. Blood. 123:2652–2662.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Youle RJ and Strasser A: The BCL-2 protein
family: Opposing activities that mediate cell death. Nat Rev Mol
Cell Biol. 9:47–59. 2008. View Article : Google Scholar
|
|
41
|
Baldin V, Lukas J, Marcote MJ, Pagano M
and Draetta G: Cyclin D1 is a nuclear protein required for cell
cycle progression in G1. Genes Dev. 7:812–821. 1993. View Article : Google Scholar : PubMed/NCBI
|
